Quintiles IMS Holdings Inc (Q) Analysts See $1.03 EPS

July 18, 2017 - By Migdalia James

 Quintiles IMS Holdings Inc (Q) Analysts See $1.03 EPS
Investors sentiment increased to 1.75 in Q4 2016. Its up 1.00, from 0.75 in 2016Q3. It increased, as 39 investors sold Quintiles IMS Holdings Inc shares while 93 reduced holdings. 85 funds opened positions while 146 raised stakes. 216.20 million shares or 97.25% more from 109.60 million shares in 2016Q3 were reported.
Harris Ltd Partnership invested 0.36% of its portfolio in Quintiles IMS Holdings Inc (NYSE:Q). Bluemountain Capital Mngmt Ltd has 526 shares. Vaughan Nelson Investment Mngmt Lp stated it has 519,837 shares. Alkeon Cap Lc has 1.05% invested in Quintiles IMS Holdings Inc (NYSE:Q) for 700,000 shares. Suntrust Banks holds 5,687 shares. Millennium Mngmt Limited Company holds 0.02% or 117,915 shares. Utah Retirement Sys, a Utah-based fund reported 25,660 shares. 5,682 were reported by Commerzbank Aktiengesellschaft Fi. Livforsakringsbolaget Skandia Omsesidigt reported 7,033 shares. Qs Invsts reported 0.01% of its portfolio in Quintiles IMS Holdings Inc (NYSE:Q). Jpmorgan Chase invested in 23,947 shares or 0% of the stock. Moreover, Franklin Resources has 0.05% invested in Quintiles IMS Holdings Inc (NYSE:Q). Opus Point Ptnrs Management Ltd reported 3,418 shares. Beaconlight Llc has invested 2.08% in Quintiles IMS Holdings Inc (NYSE:Q). The Ontario – Canada-based Highstreet Asset Mgmt has invested 0.27% in Quintiles IMS Holdings Inc (NYSE:Q).

Analysts expect Quintiles IMS Holdings Inc (NYSE:Q) to report $1.03 EPS on July, 26.They anticipate $0.10 EPS change or 10.75 % from last quarter’s $0.93 EPS. Q’s profit would be $222.74 million giving it 21.86 P/E if the $1.03 EPS is correct. After having $1.01 EPS previously, Quintiles IMS Holdings Inc’s analysts see 1.98 % EPS growth. The stock increased 0.78% or $0.7 during the last trading session, reaching $90.08. About 958,313 shares traded or 0.41% up from the average. Quintiles IMS Holdings Inc (NYSE:Q) has risen 27.93% since July 18, 2016 and is uptrending. It has outperformed by 11.23% the S&P500.

Quintiles IMS Holdings Inc (NYSE:Q) Ratings Coverage

Among 18 analysts covering Quintiles Transnational (NYSE:Q), 5 have Buy rating, 0 Sell and 13 Hold. Therefore 28% are positive. Quintiles Transnational had 36 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Quintiles IMS Holdings Inc (NYSE:Q) has “Hold” rating given on Thursday, August 20 by Zacks. On Friday, December 16 the stock rating was downgraded by Goldman Sachs to “Neutral”. Goldman Sachs initiated the shares of Q in report on Wednesday, October 5 with “Buy” rating. The firm has “Buy” rating by Mizuho given on Thursday, May 4. Stifel Nicolaus initiated the stock with “Hold” rating in Friday, October 14 report. The stock of Quintiles IMS Holdings Inc (NYSE:Q) has “Buy” rating given on Tuesday, August 25 by Zacks. SunTrust downgraded the shares of Q in report on Monday, March 28 to “Neutral” rating. Jefferies maintained Quintiles IMS Holdings Inc (NYSE:Q) rating on Tuesday, June 6. Jefferies has “Hold” rating and $8100 target. The rating was downgraded by Robert W. Baird on Wednesday, February 15 to “Underperform”. The rating was downgraded by William Blair to “Market Perform” on Thursday, December 1.

Quintiles IMS Holdings, Inc., formerly Quintiles Transnational Holdings Inc., provides integrated information and technology-enabled healthcare services. The company has market cap of $19.48 billion. The Firm operates through divisions, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. It has a 81.66 P/E ratio. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

More important recent Quintiles IMS Holdings Inc (NYSE:Q) news were published by: Nasdaq.com which released: “Q Crosses Above Average Analyst Target” on June 20, 2017, also Prnewswire.com published article titled: “Today’s Research Report Coverage on Medical Labs Stocks — Agilent …”, Seekingalpha.com published: “Quintiles IMS: A Novel Way To Invest In Biopharma” on July 17, 2017. More interesting news about Quintiles IMS Holdings Inc (NYSE:Q) was released by: Reuters.com and their article: “Quintiles IMS explores sale of contract sales business: sources” with publication date: June 21, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.